USPTO serial 87537417
TOXIKON ADVANCING YOUR INNOVATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 13, 2018
- Examiner
- MCMORROW, JANICE LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with TOXIKON ADVANCING YOUR INNOVATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William M. Bryner
William M. Bryner Kilpatrick Townsend & Stockton LLP1001 West Fourth StreetWinston-Salem, NC 27051UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Medical training and teaching; Training for handling scientific instruments and apparatus for research in laboratories; Training in the use and operation of medical equipment and consultation relating thereto | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and development; Product research and development; Chemical, biochemical, biological and bacteriological research and analysis; Biochemical research and development; Biomedical research services; Research and development in the pharmaceutical and biotechnology fields; Bacteriological research and testing; Bacteriological consultation and research; Biotechnology research; Toxicology services; Scientific laboratory services; Medical laboratory services; Medical laboratories; Medical research; Laboratory research services relating to pharmaceuticals; Chemical laboratories; Laboratory analysis in the field of bacteriology; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical products development; Research and development of vaccines and medicines; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical product evaluation; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; DNA screening for scientific research purposes; Blood analysis services; Optical laboratories; Engineering; Chemical engineering; Development and test of chemical production methods; Working on and evaluation of chemical analyses; Working on and evaluation of chemical syntheses; Analysis of the mode of action of chemical combinations on animals; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Testing the functionality of apparatus and instruments; Product testing; Product quality testing; Material testing; Product safety testing services; Testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Providing facilities for scientific research and development; Rental of laboratory apparatus and instruments | SECTION 8 - CANCELLED | — |
| 044 | Medical services; Veterinary services; Medical screening; Medical imaging services; Drug, alcohol and DNA screening for medical purposes; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Mammography testing services; Surgery; Veterinary surgery; In vitro fertilization services; Performing diagnosis of diseases; Dermatology services; Vascular screening; Medical equipment rental | SECTION 8 - CANCELLED | — |
| 045 | Legal advisory services; Legal consulting services in the field of listing and tracking of foreign and domestic government regulatory requirements, for obtaining permits and regulatory compliance; Regulatory compliance consulting in the field of medical device and new drugs approval; Reviewing standards and practices to assure compliance with pharmaceutical and medical laws and regulations | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Toxikon Corporation
- Other trademarks owned by Toxikon Corporation
- Other trademarks owned by Toxikon Corporation
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named TOXIKON ADVANCING YOUR INNOVATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 13, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 16, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 16, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 16, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 16, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 7, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 13, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 28, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 25, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 20, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2017 | NWAP | NEW APPLICATION ENTERED | — |